Cargando…
Associations between polygenic loading, psychosis liability, and clozapine use
INTRODUCTION: Predictors consistently associated with psychosis liability and course of illness in schizophrenia (SCZ) spectrum disorders (SSD), including the need for clozapine treatment, are lacking. Longitudinally ascertained medication use may empower studies examining associations between polyg...
Autor principal: | Luykx, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596276/ http://dx.doi.org/10.1192/j.eurpsy.2023.258 |
Ejemplares similares
-
Polygenic risk, familial liability and stress reactivity in psychosis: an experience sampling study
por: Schick, Anita, et al.
Publicado: (2023) -
Polygenic liability for schizophrenia and childhood adversity influences daily‐life emotion dysregulation and psychosis proneness
por: Pries, L.‐K., et al.
Publicado: (2020) -
Clozapine in First Episode Psychosis: The best is delayed
por: Rodrigues, J. B., et al.
Publicado: (2023) -
Clozapine in first episode psychosis – the experience of a Portuguese center
por: Soares Da Costa, I., et al.
Publicado: (2023) -
Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments
por: Vainieri, Isabella, et al.
Publicado: (2022)